Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_19_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
61 Мб
Скачать
294
https://t.me/medicina_free
Glossary of common terms
edema and malar mounds is often not easily discernable. The presence of excess tissue along with bulge is characteristic of a malar mound versus malar edema.
Masseter The masseter is a muscle of mastication and is an extremely powerful muscle. It is
responsible for patients who suffer from TMJD. A hyperactive masseter muscle is a broader look to the lower jaw. Think of Angelina Jolie; she has a well-defined jaw with an active masseter, enhancing her unique jaw presentation. When neuromodulation is placed in the masseter muscle, it can create a slimmer jawline and reduce TMJD’s pain and discomfort. It is important to note that if the patient has some jowls and or lax skin, treating this area will slim the jawline while enhancing the jowls and exacerbate the lax skin. This muscle is responsible for elevating and protruding the chin.
Mentalis The mentalis (levator Menti) are two deep but small conical fasciculus structures that
lie on the side of the frenulum of the lower lip. It arises from the incisive fosa of the mandible and then on the descent attaches to the skin on the chin. It is responsible for wrinkling the skin on the chin in an upward fashion. When the mentalis is activated, it raises the lower lip base, thus allowing for protrusion of the lower lip to an everted position to allow for easy drinking. This muscle is also responsible for eliciting emotions of doubt and concern. Over action of this muscle will also create a deep mental crease under the lip.
Nasalis This thin muscle lays across the bridge of the nose and connects with the process. It is
at this connection when you can often see a static rhytid across the bridge of the nose. The nasalis muscle draws the tissue up and creates a bunny nose appearance. When active, the nasalis will pull the ala up and, depressors the cartilage of the bridge of the nose. An active nasalis will create horizontal lines on the bridge of the nose and diag­onal lines on either side of the nose near the inner canthus.
Orbiculars oculi The orbicularis oculi is a broad, flat, and elliptical muscle that surrounds
the orbital rim’s circumference and is responsible for the eyelids closure. Much like the orbicularis oris muscle, it is also a sphincter muscle and is ultimately a depressor muscle. The muscle spans several facial regions, which include the eyelid, the cheek, and the forehead. This sphincter muscle’s primary function is to act as a depressor muscle. It is partly responsible for the early onset of creasing in the skin at the lateral canthal area and nasalis line.
Orbicularis oris muscle (labi) The orbicularis oris muscle is a superficial yet complex
sphincter muscle that encircles the mouth. This muscle is extremely superficial to the upper and lower lips. It is responsible for closing the mouth and protruding the lips. The deep portion of this muscle is responsible for pressing the lip to the teeth. There is an upper and a lower muscle, and then it is further segmented into four quadrants (upper, lower, left, and right).
Photophobia Photophobia is light sensitivity. If injections of neuromodulation position the
eyelid to not fully close and the patients lose their ability to shield their eyes from bright light, photophobia will occur.
Platysma The platysma is a superficial muscle of the neck that lay in the subcutaneous tissue
and overlaps the sternocleidomastoid. It is considered a broadsheet of muscle with var­ious prominence that covers the majority of the lateral and anterior neck. The platysma fibers cross the clavicle and ascend medially to the side of the neck. The anterior fibers intertwine to the menti while other fibers connect to the mandible and the lower lip. The platysma is responsible for accentuating skin laxity in the aging process. Be careful in the central portion treating bands over the thyroid notch. Just below the thyroid notch
Glossary of common terms
https://t.me/medicina_free
sits the laryngeal prominence and below that is the cricothyroid ligament. If a neuro­modulator was to affect here, the patient could have significant trouble swallowing. The platysma is responsible for tensing the neck.
Procerus The procerus is a pyramid-shaped muscle located within the glabellar region. It
extends from the nasal bone to roughly the middle of the forehead between the eye­brows; this is where it attaches to the frontalis muscle. When injected with neuromo­dulator, it raises the bridge of the nose and softens the horizontal rhytids on the bridge of the nose. It is responsible for drawing the medial brows down, hence its depressor function.
Ptosis Ptosis is a greek word developed in reference to dropped or fallen. Patients can expe-
rience ptosis after neuromodulation if the injections are not precise. Ptosis can occur when treating any muscle that is an elevator. Commonly ptosis is seen in the eyebrow, eyelid, or smile.
Risorius muscle This is a superficial muscle of expression. This muscle pulls the corners
of the mouth laterally; it runs through the masseter muscle originating in then fascia. Understanding the anatomical position of this muscle is critical when treating a patient for TMJD. This muscle aids in a number of dynamic expressions such as smiling, grima­cing, laughing, and so many others.
Sclera The sclera is the white outermost portion of the part of the eye. Urticaria Urticaria is also referred to as hives where wheals rise in the skin due to chemical
mediators’ release. Many factors cause this skin eruption. In terms of urticaria associated with neuromodulation, it would be an IgE mediated drug reaction. Over the counter antihistamine medication is recommended should a patient experience urticaria post­treatment.
Xerophthalmia Xerophthalmia is a condition known as dry eye or aqueous deficiency.
Neuromodulation can also be used to treat aqueous deficiency of the eye. If the patient suffers from an aqueous deficiency treating the orbicularis oculi muscle will help reduce contractility and blinking, resulting in a slowed pump motility, improving the eye’s dryness.
Zygomatic major This superficial muscle inserts on the lateral aspect of the zygomatic
bone posterior to the zygomatic minor muscle. This muscle inserts into the orbicularis oris, the DAO, and the levator angel oris. The zygomatic major muscles draws the angle of the mouth up and out when smiling or laughing. It attaches to the zygomatic bone, and at times it will snuggle under the orbicularis oculi muscle. This muscle is another crucial muscle to avoid when injecting the lateral canthal lines, and the DAO as the smile can be interrupted in an unnatural and displeasing way.
Zygomatic minor The zygomatic minor is a superficial muscle. The ZM elevates the
upper lip outward and upward, allowing to show the maxillary teeth. This muscle sits beneath the orbicularis oculi on the zygomatic bone and connects to the subcutaneous tissue of the upper lateral lip muscle, and sits on the lateral portion of the zygomaticus bone. The ZM is essential in the function of smiling. This muscle can be inadvertently injected when the lateral canthal lines are treated in the ill-prepared injector’s hands.
295
This page intentionally left blank
https://t.me/medicina_free
Index
https://t.me/medicina_free
Note: Page numbers followed by f indicate figures and t indicate tables.
A
Acetylcholine release inhibitors, 17, 19 Aesthetic new patient history
current skin care regimen, 263–264f in house use only, 264–265f medical history, 263f
Aftercare instructions, 258–259, 269–270,
269f
Aging
aging face
effects, 69–71, 70f onset and pace, 69 reasons, 71
aging muscles, 77–78, 78f intrinsic and extrinsic aging, 71–72 patient assessment
animation, 81 art of assessment, 81f consultation, 79–80 ideas, 80 at rest and in motion, 81–82 rotation, 82
tilting, 82 patient selection, 78–79 physical assessment, 82 static vs. dynamic lines
concomitant procedures, 92–95
consult process, 90–92
definition, 84–85
patient expectations, 85–89 upper face assessment
brows, 84
frontalis, 83
Mephisto sign, 83
orbicularis oculi, 84 youthfulness, 72–75, 73–74f,76f
Aging self, 2 Alcoholic beverages, 277 Allergy, 35 Anatomy, 5–6. See also Facial anatomy Animation, 81 Anti-aging, 13
Anti-inflammatory/blood thinning
medications, 277 Asymmetries, 254 Autonomic dysfunction, 27 Axillary Hyperhidrosis, 30
B
Body dysmorphia, 78 Botox, 13, 98t, 100–102, 269–270, 269f Botox Cosmetic, 23 Botox supply list, 289
®
Botox Botulinum toxin A (BoNT-A), 13, 15t
Botulism, 46 Breathing/swallowing disorders, 38–39 Brow ptosis, 238–239 Brows, 84 Buccolabial muscle group, 63–65 Bunny lines
treatment, 3–5, 11
acetylcholine release inhibitors, 17, 19 binding phase, 20 blockade phase, 21 Botox Cosmetic, 23 Clostridium,17 commercially available variety, 23–26 cosmetic and therapeutic uses, 26–27 Dysport (abobotulinumtoxinA), 24 extrusion force, 236 internalization process, 20 Jeuveau (prabotulinumtoxinA-xvfs), 24 mechanism of action, 20 Merz Aesthetics, 24 nervous system, 18–19 process, 20–22, 21f release and nerve terminal reaction, 22–23 risk categories, 236
assessment, 182 complimentary locations, 181 documentation, 181–182 dosing, 181 duration, 184 Dysport allergy, 186–187, 186f
297
298
https://t.me/medicina_free
Index
Bunny lines (Continued)
emotion, 180 equipment, 182 follow up and special consideration, 184,
184–185t
indications for treatment, 180 muscles in treatment area, 180 muscles to be treated in the targeted zone,
180–181 pre-procedure steps, 182–183 results, 183 special considerations, 181 technique, 183 treatment area, 180 treatment goals, 181
Business relationships, 251–252 Buying followers, 250
C
Cardiovascular disease, 37 Chin
assessment, 217 complimentary locations, 216 documentation, 216 dosing, 216 duration, 219 Dysport allergy, 221–223, 221–222f emotion, 215 equipment, 216–217 follow up and special consideration,
219–220, 220–221t indications for treatment, 215 muscles in treatment area, 215 muscles to be treated in the targeted zone,
215–216 pre-procedure steps, 217–218 results, 219 special considerations, 216 technique, 218–219 treatment area, 215 treatment goals, 216
Circumorbital group, 65
corrugator supercilii, 61 levator palpebrae superiors, 61 orbicularis oculi, 61
Clostridium, 17, 29
CO
resurfacing/eye surgery, 37
2
Common myths, 45–46 Complaint, 10 Complications, 7
brow ptosis, 238–239 complications section, 235 cosmetic application dosing, 239 frontalis muscles, 240 glabellar complex facial lines, 239–240 lateral canthal lines, 240–241 lid ptosis, 239 management
static and dynamic rhytids, 241–242,
241–242f
understanding risk, 242–244t
negative sequela/displeasing results, 235 paresis, 235 ptosis risk, 240 reconstitution, 235 toxin spread
allergic reactions, 237 drugs intended effect, 236–237 extrusion force, 236 immunogenicity, 238 risk categories, 236
transient ptosis, 238–239 Compound sphincter muscle group, 65 Concomitant procedures
aging process, 94
decision process, 94–95
neuromodulation, 92–93
treatment options, 93–94 Confidence Tools, 257 Consult process, 90–92 Cosmetic application dosing, 239 Cosmetic providers, 2 Cosmetic uses, 26 Crows feet injections
assessment, 151–152
complimentary locations, 150
documentation, 150–151
dosing, 150
duration, 155
Dysport allergy, 158, 159–160f, 160–162,
162f
emotion, 149
Index
https://t.me/medicina_free
299
equipment, 151 follow up and special consideration,
155–156, 156–157t
indications for treatment, 149 muscles in treatment area, 149 muscles to be treated in the targeted zone,
149
pre-procedure steps, 152–153, 153f results, 155 special considerations, 149–150 technique, 153–155, 154f treatment area, 149 treatment goals, 150
D
Deep lines, 45 Dermal filler, 11 Discount, 8–9 Documentation, 259–260 Downtime, 8, 46 Drug to drug interactions, 41–43 Dysport (abobotulinumtoxinA), 24, 31, 99t,
103
E
Education, 256–257 Emails, 247–248 Emotionally charged side effects, 34 Emotional well-being, 2 Extrinsic aging, 71–72 Eyebrow lift
assessment, 165 complimentary locations, 164 documentation, 164 dosing, 164 duration, 167 Dysport allergy, 169–171, 170–171f emotion, 163 equipment, 164–165 follow up and special consideration, 167,
168–169t
indications for treatment, 163 muscles in treatment area, 163 muscles to be treated in the targeted zone,
163
pre-procedure steps, 165–166
results, 167 special considerations, 163 technique, 166–167 treatment area, 162–163 treatment goals, 164
Eyelid wrinkle. See Lower eyelid wrinkle
F
Face, aging
effects, 69–71, 70f onset and pace, 69
reasons, 71 Facelift, 46 Face Tune, 3 Facial anatomy
buccolabial muscle group, 63–65
circumorbital group, 61
compound sphincter muscle group, 65
for cosmetic purposes
bone and cartilage, 68f deep muscles, 59f muscles, 58–59f skin, 49–50, 49f superficial fat pads, 57f superficial nerve, 67f vessels, 67f
fat pads, 56–58
hypodermis, 53–56
muscles by facial groups and areas, 60t,
65–66 muscles of the face, 58–59 nasal muscle group, 61–63 skeletal structure, 66–68 soft tissue, 50–52
Facial features, 1 Fat pads, 56–58 FDA approval for therapeutic use, 29 Follow up call, 259 Frontalis, 83, 240 Frontalis-forehead wrinkles
assessment, 131, 132f complimentary locations, 130 documentation, 130–131 dosing, 130 duration, 134 emotion, 129
300
https://t.me/medicina_free
Index
Frontalis-forehead wrinkles (Continued)
equipment, 131 follow up and special consideration,
134–135, 135–136t
glabellar complex with frontalis,
140–141f, 141–148, 143–146f
indications for treatment, 129 muscles in treatment area, 129 muscles to be treated in the targeted zone,
129
peaked brow expression, 147–148f, 148 results, 134 special considerations, 129–130 static and dynamic rhytids, 137– 138f,
139–141 treatment area, 129 treatment goals, 130
Funny filters/unrealistic filters, 3
G
Gastroenterology, 27 Glabellar complex facial lines, 239–240 Glabellar complex injections
assessment, 111 complimentary locations, 110 documentation, 110 dosing, 110 duration, 113–114 Dysport allergy
dynamic expression lines, 122–124,
123f
frown lines, 119–122, 119–120f,
124–126, 124f
lash line, 126–128, 126–127f static lines, 116–117f, 117–119,
122–124, 122f, 128–129, 128f
symptoms, 116 emotion, 109 equipment, 110–111 follow up and special consideration, 114,
115t
frown lines, 108–109, 108f indications for treatment, 109 muscles in treatment area, 109 muscles to be treated in the targeted zone,
109
pre-procedure steps, 111–112, 112f results, 113
special considerations, 109 technique, 112–113 treatment goals, 110
Gummy smile
assessment, 198 complimentary locations, 197 documentation, 197 dosing, 197 duration, 200 Dysport allergy, 202–207, 202–203f,
205–206f
emotion, 196 equipment, 197–198 follow up and special consideration, 200,
201t
indications for treatment, 196 muscles in treatment area, 196 muscles to be treated in the targeted
zone, 196 pre-procedure steps, 198–199 results, 199– special considerations, 196 technique, 199 treatment area, 196 treatment goals, 197
200
H
History, 29–31 Human albumin and viral diseases
transmission, 39
Hyperhidrosis injection technique
axillae treatment, 232 duration, 234 follow up and special consideration,
233–234, 233–234t indication, 231 palm treatment, 233, 233–234t pricing, 231 safety, 231 sweat glands, 231 treatment area, 231
Hypersensitivity, 35 Hypodermis
collagen, 55 deflation, 54 elastin, 54 hyaluronic acid, 55
Index
https://t.me/medicina_free
301
lipocytes, 53 subcutaneous layer, 53 subcutaneous tissue sections, 53
I
Ice, 257–258 Identity, 1 Immunogenicity, 39 Infection/rash, 35 Injectables, 1–2, 4–5 Injection anatomy, 5–6 Injection preparation. See Reconstitution Injection site, 38 Injection technique
bunny lines (see Bunny lines) chin (see Chin) crows feet injections (see Crows feet
injections)
eyebrow lift (see Eyebrow lift) frontalis-forehead wrinkles
(see Frontalis-forehead wrinkles)
glabellar complex injections (see Glabellar
complex injections)
gummy smile (see Gummy smile) hyperhidrosis (see Hyperhidrosis injection
technique)
marionette lines (see Marionette lines) platysmal bands (see Platysmal bands) smokers lines (see Smokers lines)
Intrinsic aging, 71–72
Point out the asymmetries, 254
Reconstitution, 258 Looks and image, 1 Lower eyelid wrinkle
assessment, 174
complimentary locations, 173
documentation, 173–174
dosing, 173
duration, 176–177
Dysport allergy, 179–180, 179f
emotion, 172
equipment, 174
follow up and special consideration, 177,
177–178t
indications for treatment, 172
muscles in treatment area, 172
muscles to be treated in the targeted zone,
172 pre-procedure steps, 175 results, 176 special considerations, 172–173 technique, 175–176 treatment area, 172 treatment goals, 173
Lower lip (elevators, retractors, and evertors)
depressor anguli oris (DAO), 64–65 depressor labii inferioris (DLI), 64 mentalis, 65
Luxurious lifestyle, 9–10
J
Jeuveau (prabotulinumtoxinA-xvfs), 24, 31,
99t, 103
L
Lateral canthal lines, 240–241.
See also Crows feet injections
Lid ptosis, 239 List for success, 6
Aftercare instructions, 258–259 Be the Expert, 253 Confidence Tools, 257 Documentation, 259–260 Educate, 256–257 Follow up Call, 259 Ice, 257–258 Photos, 254–256
M
Makeup, 279 Marionette lines
assessment, 209–210 complimentary locations, 208 documentation, 208–209 dosing, 208 duration, 211–212 Dysport allergy, 213, 214f emotion, 207 equipment, 209, 209f follow up and special consideration, 212,
212–213t indications for treatment, 207 muscles in treatment area, 207 muscles to be treated in the targeted zone,
207
302
https://t.me/medicina_free
Index
Marionette lines (Continued)
pre-procedure steps, 210 results, 211 special considerations, 207–208 technique, 210–211 treatment area, 207 treatment goals, 208
Marketing
business relationships, 251–252 buying followers, 250 emails, 247–248 fun facts and tidbits, 251 online presence, 247 post care, 248–250 pre care, 248 referral program, 251
stock photos/memes, 250 Mephisto sign, 83 Merz Aesthetics, 24 Minimal downtime, 8 Minimally invasive procedures, 3,
6–7
Muscles, aging, 77–78, 78f
N
Nasalis lines. See Bunny lines Nasal muscle group, 66
depressor septi, 62
levator labii superioris alaeque nasi
(LLSAN), 62–63 nasalis, 62 procerus, 61–62
Neurological disorder, 36 Neurology, 26 Neuromodulator, 2, 4–5, 11, 13, 14f Neurotoxin, 13, 14f Neurotoxins consent
payment, 273–274 photographs, 273 post treatment instructions, 272–273 pregnancy, allergies and neurologic
disease, 273 pre treatment instructions, 272 results, 274–275 rhytids (wrinkles), 271 risks and complications, 271–272
Non-surgical cosmetic industry, 2–3 Nonsurgical procedures, 11
O
OnabotulinumtoxinA, 30–31 Online presence, 247 Ophthalmology, 26 Orbicularis oculi, 84 Orbicularis oris, 65 Otolaryngology, 26
P
Pain therapy, 26 Patient satisfaction, 78–79 Patient selection, 78–79 Perioral rhytids. See Smokers lines Photo consent form, 287–288, 287– 288f Photos, 254–256 Platysmal bands
assessment, 225f, 226 complimentary locations, 225 documentation, 225–226 dosing, 225 Dysport allergy, 229–230, 230f emotion, 224 equipment, 226 follow up and special consideration, 228,
228–229t
indications for treatment, 224 muscles in treatment area, 224 muscles to be treated in the targeted
zone, 224 pre-procedure steps, 226–227 results, 228 special considerations, 224 technique, 227–228 treatment area, 223 treatment goals, 225
Policy and procedure
authorized personnel documentation, 283 development of plan, 285 evaluation and competency, 282–283 limitations, 283 policy, 281 protocol for administration, 283–285 purpose, 281 record keeping, 282 setting, 281 supervision, 281–282 training/education, 282
Post care guidelines email, 269–270, 269f
Index
https://t.me/medicina_free
303
Post treatment instructions, 279–280 Pre care guidelines email, 267, 267f Pregnancy/lactating, 35 Pre treatment instructions, 277 Profound Radiofrequency device
treatment, 85
Ptosis risk, 240
R
Reconstitution, 258
Botox
calculation, 100–102 dilution instructions, 98t
Dysport
calculation, 103 dilution instructions, 99t
Jeuveau
calculation, 103 dilution instructions, 99t
novice areas and advanced areas, 104–105 recommendations, 97–98 storage and handling, 100–102t, 104 suggested dosing guidelines, 100–102t Xeomin
calculation, 102–103 dilution instructions, 99t
Referral program, 251 Reinnervation, 22 Return on investment (ROI), 245, 246t Rotation, 82
S
Safety
adverse events, 33 ALL neuromodulators
allergy, 35 hypersensitivity, 35 infection/rash, 35 neurological disorder, 36
pregnancy/lactating, 35 drug to drug interactions, 41–43 emotionally charged side effects, 34 fixed needles, 33–34 injector
breathing/swallowing disorders, 38–39
cardiovascular disease, 37
CO
resurfacing/eye surgery, 37
2
human albumin and viral diseases
transmission, 39 immunogenicity, 39 injection site, 38 special events, 37 thick sebaceous skin, 36 zinc deficiency, 40–41
side effects, 34
silicone stoppers, 34–35 Sausage poison, 29 Side effects, 45 Silicone stoppers, 34–35 Skeletal structure, 66–68 Smokers lines
assessment, 190
complimentary locations, 188
documentation, 189
dosing, 188–189
duration, 192
Dysport allergy, 194–196, 194–195f
emotion, 188
equipment, 189
follow up and special consideration, 192,
192–193t
indications for treatment, 187
muscles in treatment area, 188
muscles to be treated in the targeted zone,
188 pre-procedure steps, 190 results, 191 special considerations, 188 technique, 190–191 treatment area, 187 treatment goals, 188
Snap chat filters and apps, 3 Social media, 3, 7–8, 11–12 Soft tissue
dermal layer, 52 dermis, 50 epidermis, 50 keratinocytes, 52 layers, 50 skin, 50–52 tissue planes, 50
Start up fees, 245, 246t Static rhytids, 22, 47 Static vs. dynamic lines
concomitant procedures
aging process, 94